Advancing Palliative Care Integration in Hematology: Building Upon Existing Evidence

被引：0
作者：
Gregg A. Robbins-Welty
Jason A. Webb
Dan Shalev
Areej El-Jawahri
Vicki Jackson
Chandler Mitchell
Thomas W. LeBlanc
机构：
[1] Duke University School of Medicine Durham,Department of Medicine
[2] Duke University School of Medicine,Department of Psychiatry and Behavioral Sciences
[3] Knight Cancer Institute,Division of Hematology/Medical Oncology
[4] Oregon Health & Science University,Division of Geriatrics and Palliative Medicine, Department of Medicine
[5] Weill Cornell Medicine,Division of Oncology, Dana Farber
[6] Department of Psychiatry,Department of Medicine, Division of Palliative Care and Geriatric Medicine
[7] Weill Cornell Medicine,Division of Hematologic Malignancies and Cellular Therapy
[8] Massachusetts General Hospital,undefined
[9] Massachusetts General Hospital,undefined
[10] Harvard Medical School,undefined
[11] University of Pittsburgh School of Medicine,undefined
[12] Duke University School of Medicine,undefined
来源：
Current Treatment Options in Oncology | 2023年 / 24卷
关键词：
Palliative care; Hematologic malignancies; Symptom management;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Patients with hematologic malignancies and their families are among the most distressed of all those with cancer. Despite high palliative care-related needs, the integration of palliative care in hematology is underdeveloped. The evidence is clear that the way forward includes standard-of-care PC integration into routine hematologic malignancy care to improve patient and caregiver outcomes. As the PC needs for patients with blood cancer vary significantly by disease, a disease-specific PC integration strategy is needed, allowing for serious illness care interventions to be individualized to the specific needs of each patient and situation.
引用
收藏
页码：542 / 564
页数：22
相关论文
共 488 条
  • [1] Rao VB(2021)Early palliative care services and end-of-life care in medicare beneficiaries with hematologic malignancies: a population-based retrospective cohort study J Palliat Med 24 63-70
  • [2] Belanger E(2017)Early palliative care for patients with hematologic malignancies: is it really so difficult to achieve? Curr Hematol Malig Rep 12 300-308
  • [3] Egan PC(2009)Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the project enable ii randomized controlled trial JAMA [Internet] 302 741-9
  • [4] Leblanc TW(2010)Early palliative care for patients with metastatic non–small-cell lung cancer N Engl J Med [Internet] 363 733-742
  • [5] Olszewski AJ(2015)Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial J Clin Oncol 33 1438-1445
  • [6] LeBlanc TW(2015)Benefits of early versus delayed palliative care to informal family caregivers of patients with advanced cancer: outcomes from the ENABLE III randomized controlled trial J Clin Oncol [Internet] 33 1446-52
  • [7] Roeland EJ(2008)Effectiveness of specialized palliative care: a systematic review JAMA [Internet] 299 1698-1709
  • [8] El-Jawahri A(2016)Association between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis JAMA [Internet] 316 2104-2114
  • [9] Bakitas M(2018)European Society for Medical Oncology (ESMO) position paper on supportive and palliative care Ann Oncol [Internet] 29 36-43
  • [10] Lyons K(2011)The symptom burden of patients with hematological malignancy: a cross-sectional observational study J Pain Symptom Manage [Internet] 42 432-442
12345678910